Related Experiment Video
Updated: Feb 1, 2026

Live Cell Imaging of the TGF- β/Smad3 Signaling Pathway In Vitro and In Vivo Using an Adenovirus Reporter System
Published on: July 30, 2018
MicroRNA-323 suppresses nerve cell toxicity in cerebral infarction via the transforming growth factor-β1/SMAD3
Fengli Che1, Huishan Du1, Jianchao Wei1
1Department of Neurology, Beijing Luhe Hospital Capital Medical University, Beijing 101145, P.R. China.
Abstract:
In the present study, the aim was to investigate the function of microRNA‑323 (miR‑323) in cerebral infarction and its underlying mechanism. A rat model of cerebral infarction was established and hippocampal tissues were analyzed. In addition, to further understand the role of miR‑323, PC12 cells were transfected with miR‑323 mimics or inhibitors and subjected to hypoxia to model cerebral infarction. Reverse transcription‑quantitative polymerase chain reaction was used to measure the expression of miR‑323. A luciferase reporter assay was conducted to analyze miR‑323 target sites the partial sequence of the 3'‑untranslated region of SMAD3 mRNA in vitro. Western blot analysis was also used to analyze transforming growth factor‑β1 (TGF‑β1) and SMAD3 protein expression levels. It was observed that miR‑323 expression was significantly upregulated in rats with cerebral infarction compared with rats in the sham‑control group. In addition, overexpression of miR‑323 induced nerve cell toxicity and reduced nerve cell growth in an in vitro model of cerebral infarction, whereas downregulation of miR‑323 caused the opposite effects on nerve cell toxicity and growth in this model. In addition, overexpression of miR‑323 directly targeted and suppressed SMAD3 expression in the in vitro model of cerebral infarction, while inhibition of miR‑323 induced SMAD3 expression. The use of a SMAD3 inhibitor suppressed the effect of anti‑miR‑323 on nerve cell toxicity in the in vitro model of cerebral infarction. Collectively, these findings suggested that miR‑323 suppresses nerve cell apoptosis in cerebral infarction via the TGF‑β1/SMAD3 signaling pathway.
Insights
MicroRNA-323 (miR-323) is upregulated in cerebral infarction, promoting nerve cell toxicity. Inhibiting miR-323 protects against this damage by targeting the TGF-β1/SMAD3 pathway, offering a potential therapeutic strategy.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Cerebral infarction, a major cause of stroke, involves complex molecular mechanisms.
- MicroRNAs (miRNAs) play critical roles in regulating cellular processes, including those relevant to ischemic brain injury.
- Understanding the specific roles of miRNAs like microRNA-323 (miR-323) is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the functional role of miR-323 in cerebral infarction.
- To elucidate the underlying molecular mechanism of miR-323 action in this condition.
- To explore the potential of targeting miR-323 for therapeutic intervention.
Main Methods:
- Establishment of a rat model of cerebral infarction and use of PC12 cells under hypoxic conditions.
- Quantification of miR-323 expression using reverse transcription-quantitative polymerase chain reaction (RT-qPCR).
- Assessment of miR-323's direct targets using luciferase reporter assays and protein expression via Western blot analysis for SMAD3 and TGF-β1.
Main Results:
- miR-323 expression was significantly increased in cerebral infarction models.
- Overexpression of miR-323 exacerbated nerve cell toxicity and reduced cell growth, while inhibition had protective effects.
- miR-323 was found to directly target and suppress SMAD3 expression, a key component of the TGF-β1/SMAD3 signaling pathway.
Conclusions:
- miR-323 plays a detrimental role in cerebral infarction by promoting nerve cell apoptosis.
- The TGF-β1/SMAD3 signaling pathway is implicated in miR-323's mechanism of action.
- Modulating miR-323 levels presents a potential therapeutic avenue for treating cerebral infarction.
More Related Videos
05:45Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
Published on: October 10, 2025
07:49Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling
Published on: August 3, 2018
Related Concept Videos
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Hedgehog Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MicroRNAs
Basic signals of Fourier Transform
The sinc function, defined as sinc(x) = sin(πx)/(πx), is particularly notable for its symmetry and behavior at...
Non-Canonical Wnt Signaling Pathways